The store will not work correctly when cookies are disabled.
ethyl 4-(benzylselanyl)-6-chloroquinoline-2-carboxylate
ID: ALA4645980
PubChem CID: 156019220
Max Phase: Preclinical
Molecular Formula: C19H16ClNO2Se
Molecular Weight: 404.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Se]Cc2ccccc2)c2cc(Cl)ccc2n1
Standard InChI: InChI=1S/C19H16ClNO2Se/c1-2-23-19(22)17-11-18(24-12-13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)21-17/h3-11H,2,12H2,1H3
Standard InChI Key: NOEPEYZAGNZWNR-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
27.2177 -12.7820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2165 -13.6015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9246 -14.0105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9228 -12.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6314 -12.7784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6321 -13.5974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3407 -14.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0489 -13.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0442 -12.7715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3351 -12.3682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3424 -14.8217 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
30.0509 -15.2288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7494 -12.3586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5085 -14.0096 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.4596 -12.7629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1648 -12.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8750 -12.7543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7444 -11.5414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.0526 -16.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3453 -16.4505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3466 -17.2669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0557 -17.6749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7649 -17.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7601 -16.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
9 13 1 0
2 14 1 0
13 15 1 0
15 16 1 0
16 17 1 0
13 18 2 0
12 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.76 | Molecular Weight (Monoisotopic): 405.0035 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |